Non contrast-enhanced magnetic resonance imaging

DEVICE2 trials

Sponsors

Mario Negri Institute for Pharmacological Research

Conditions

C3 GlomerulonephritisC3 GlomerulopathyDense Deposit DiseaseHealthyIC-MPGNImmune Complex Membranoproliferative Glomerulonephritis

Unknown Phase

Renal NCE-MRI in Healthy Volunteers

CompletedNCT02618460

Mario Negri Institute for Pharmacological ResearchHealthy

Start: 2015-01-31End: 2015-11-30Updated: 2016-01-28

Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

CompletedNCT03723512

Mario Negri Institute for Pharmacological ResearchC3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease +2

Start: 2018-12-06End: 2021-02-17Updated: 2021-11-26

Related Papers

Functional Magnetic Resonance Imaging to Monitor Disease Progression: A Prospective Study in Patients with Primary Membranoproliferative Glomerulonephritis

The Nephron journals/Nephron journals2023-11-032 citations

POS-018 PHASE CONTRAST MAGNETIC RESONANCE IMAGING TO ASSESS RENAL PERFUSION IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

Kidney International Reports2022-06-01